These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28094767)

  • 21. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of an insulin-induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element-binding protein-mediated lipogenesis.
    Jiang SY; Yang X; Yang Z; Li JW; Xu MQ; Qu YX; Tang JJ; Li YF; Wang L; Shao YW; Meng XY; Hu H; Song BL; Rao Y; Qi W
    Hepatology; 2022 Nov; 76(5):1466-1481. PubMed ID: 35102596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-27b Depletion Enhances Endotrophic and Intravascular Lipid Accumulation and Induces Adipocyte Hyperplasia in Zebrafish.
    Hsu CC; Lai CY; Lin CY; Yeh KY; Her GM
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions.
    Abu-Elheiga L; Wu H; Gu Z; Bressler R; Wakil SJ
    J Biol Chem; 2012 Apr; 287(15):12578-88. PubMed ID: 22362781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
    Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y
    J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human sterol regulatory element-binding protein 1a contributes significantly to hepatic lipogenic gene expression.
    Bitter A; Nüssler AK; Thasler WE; Klein K; Zanger UM; Schwab M; Burk O
    Cell Physiol Biochem; 2015; 35(2):803-15. PubMed ID: 25634759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LRH-1-dependent glucose sensing determines intermediary metabolism in liver.
    Oosterveer MH; Mataki C; Yamamoto H; Harach T; Moullan N; van Dijk TH; Ayuso E; Bosch F; Postic C; Groen AK; Auwerx J; Schoonjans K
    J Clin Invest; 2012 Aug; 122(8):2817-26. PubMed ID: 22772466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men.
    Fahlbusch P; Knebel B; Hörbelt T; Barbosa DM; Nikolic A; Jacob S; Al-Hasani H; Van de Velde F; Van Nieuwenhove Y; Müller-Wieland D; Lapauw B; Ouwens DM; Kotzka J
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of Hepatic Lipogenesis by Loliolide and Pinoresinol from
    Kim SY; Lee JY; Jhin C; Shin JM; Kim M; Ahn HR; Yoo G; Son YJ; Jung SH; Nho CW
    J Agric Food Chem; 2019 Nov; 67(45):12419-12427. PubMed ID: 31610126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation.
    Li H; Ying H; Hu A; Hu Y; Li D
    Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. REV-ERBα Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver.
    Yang Z; Tsuchiya H; Zhang Y; Lee S; Liu C; Huang Y; Vargas GM; Wang L
    Am J Pathol; 2016 Nov; 186(11):2909-2920. PubMed ID: 27664470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization.
    Cheng J; Liu C; Hu K; Greenberg A; Wu D; Ausman LM; McBurney MW; Wang XD
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2783-2790. PubMed ID: 28789977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice.
    Nguyen TTP; Kim DY; Lee YG; Lee YS; Truong XT; Lee JH; Song DK; Kwon TK; Park SH; Jung CH; Moon C; Osborne TF; Im SS; Jeon TI
    Mol Cell; 2021 Sep; 81(18):3820-3832.e7. PubMed ID: 34233158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.
    Ducheix S; Vegliante MC; Villani G; Napoli N; Sabbà C; Moschetta A
    Cell Mol Life Sci; 2016 Oct; 73(20):3809-22. PubMed ID: 27522544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D Deficiency Increases Lipogenesis and Reduces Beta-Oxidation in the Liver of Diet-Induced Obese Mice.
    Borges CC; Salles AF; Bringhenti I; Mandarim-DE-Lacerda CA; Aguila MB
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(2):106-115. PubMed ID: 29710028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.